tetano
Editor, Senior Moderator
Retin Cases Brief Rep
. 2021 Sep 24.
doi: 10.1097/ICB.0000000000001195. Online ahead of print.
Acute macular neuroretinopathy following SARS-CoV-2 vaccination
Samir N Patel[SUP] 1 [/SUP], Yoshihiro Yonekawa
Affiliations
Abstract
Purpose: To present the rare case of a patient who developed acute macular neuroretinopathy following administration of a single dose adenovector coronavirus vaccine.
Methods: Retrospective chart review.
Results: A 26-year-old woman presented with paracentral scotomas in both eyes that acutely developed two days following administration of a single dose adenovector SARS-CoV-2 vaccine (Johnson & Johnson, New Brunswick, NJ). She had previously received the seasonal influenza immunization without any symptoms and denied any recent history of viral illnesses. On examination, optical coherence tomography showed parafoveal hyperreflective bands in the outer retina of both eyes without retinal thickening, and near-infrared reflectance showed wedge-shaped parafoveal lesions pointing to the fovea, both classic findings in acute macular neuroretinopathy.
Discussion: This report highlights the development of AMN after a SARS-CoV-2 vaccination in an otherwise healthy female patient. A single case cannot establish cause and effect, and millions of COVID-19 vaccines have been administered safely at the time of writing. However, this may be a rare association, and clinicians can consider inquiring about recent vaccination history in patients presenting with AMN.
. 2021 Sep 24.
doi: 10.1097/ICB.0000000000001195. Online ahead of print.
Acute macular neuroretinopathy following SARS-CoV-2 vaccination
Samir N Patel[SUP] 1 [/SUP], Yoshihiro Yonekawa
Affiliations
- PMID: 34608019
- DOI: 10.1097/ICB.0000000000001195
Abstract
Purpose: To present the rare case of a patient who developed acute macular neuroretinopathy following administration of a single dose adenovector coronavirus vaccine.
Methods: Retrospective chart review.
Results: A 26-year-old woman presented with paracentral scotomas in both eyes that acutely developed two days following administration of a single dose adenovector SARS-CoV-2 vaccine (Johnson & Johnson, New Brunswick, NJ). She had previously received the seasonal influenza immunization without any symptoms and denied any recent history of viral illnesses. On examination, optical coherence tomography showed parafoveal hyperreflective bands in the outer retina of both eyes without retinal thickening, and near-infrared reflectance showed wedge-shaped parafoveal lesions pointing to the fovea, both classic findings in acute macular neuroretinopathy.
Discussion: This report highlights the development of AMN after a SARS-CoV-2 vaccination in an otherwise healthy female patient. A single case cannot establish cause and effect, and millions of COVID-19 vaccines have been administered safely at the time of writing. However, this may be a rare association, and clinicians can consider inquiring about recent vaccination history in patients presenting with AMN.